+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Self-Monitoring Blood Glucose Strips Market 2020-2024

  • PDF Icon

    Report

  • 120 Pages
  • November 2020
  • Region: Global
  • TechNavio
  • ID: 5205105
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Global Self-Monitoring Blood Glucose Strips Market 2020-2024

The publisher has been monitoring the self-monitoring blood glucose strips market and it is poised to grow by $ 10.96 bn during 2020-2024, progressing at a CAGR of 11% during the forecast period. The reports on the self-monitoring blood glucose strips market provide a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increase in the global diabetic population, technological advances in BGM devices requiring test strips, and the availability of reimbursements. In addition, an increase in the global diabetic population is anticipated to boost the growth of the market as well.

The self-monitoring blood glucose strips market analysis includes end-user segment and geographical landscapes.

The self-monitoring blood glucose strips market is segmented as below:

By End-user
  • Hospitals and diagnostic laboratories
  • Home-care settings
  • POL

By Geographical Landscapes
  • North America
  • Europe
  • Asia
  • ROW

This study identifies the availability of test strips made from Indian silk as one of the prime reasons driving the self-monitoring blood glucose strips market growth during the next few years. Also, increasing adoption of home healthcare devices and an increase in online marketing strategies will lead to sizable demand in the market.

The self-monitoring blood glucose strips market report covers the following areas:
  • Self-monitoring blood glucose strips market sizing
  • Self-monitoring blood glucose strips market forecast
  • Self-monitoring blood glucose strips market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading self-monitoring blood glucose strips market vendors that include Abbott Laboratories, ACON Laboratories Inc., ARKRAY Inc., Ascensia Diabetes Care Holdings AG, Becton, Dickinson and Co., B. Braun Melsungen AG, F. Hoffmann-La Roche Ltd., LifeScan IP Holdings LLC, Medtronic Plc, and Nipro Corp. Also, the self-monitoring blood glucose strips market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary
  • Market Overview

Market Landscape
  • Market ecosystem
  • Value chain analysis

Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis
  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by End-user
  • Market segments
  • Comparison by End user
  • Hospitals and diagnostic laboratories - Market size and forecast 2019-2024
  • Home-care settings - Market size and forecast 2019-2024
  • POL - Market size and forecast 2019-2024
  • Market opportunity by End user

Customer landscape
Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Volume drivers - Demand led growth
  • Market challenges
  • Market trends

Vendor Landscape
  • Overview
  • Vendor landscape
  • Landscape disruption

Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories
  • ACON Laboratories Inc.
  • ARKRAY Inc.
  • Ascensia Diabetes Care Holdings AG
  • B. Braun Melsungen AG
  • F. Hoffmann-La Roche Ltd.
  • LifeScan IP Holdings LLC
  • Medtronic Plc
  • Nipro Corp.

Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibit
  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Key Finding 8
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2019 - 2024 ($ billion)
  • Global market: Year-over-year growth 2019 - 2024 (%)
  • Five forces analysis 2019 & 2024
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2019
  • End user - Market share 2019-2024 (%)
  • Comparison by End user
  • Hospitals and diagnostic laboratories - Market size and forecast 2019-2024 ($ billion)
  • Hospitals and diagnostic laboratories - Year-over-year growth 2019-2024 (%)
  • Home-care settings - Market size and forecast 2019-2024 ($ billion)
  • Home-care settings - Year-over-year growth 2019-2024 (%)
  • POL - Market size and forecast 2019-2024 ($ billion)
  • POL - Year-over-year growth 2019-2024 (%)
  • Market opportunity by End user
  • Customer landscape
  • Market share by geography 2019-2024 (%)
  • Geographic comparison
  • North America - Market size and forecast 2019-2024 ($ billion)
  • North America - Year-over-year growth 2019-2024 (%)
  • Europe - Market size and forecast 2019-2024 ($ billion)
  • Europe - Year-over-year growth 2019-2024 (%)
  • Asia - Market size and forecast 2019-2024 ($ billion)
  • Asia - Year-over-year growth 2019-2024 (%)
  • ROW - Market size and forecast 2019-2024 ($ billion)
  • ROW - Year-over-year growth 2019-2024 (%)
  • Key leading countries
  • Market opportunity by geography ($ billion)
  • Impact of drivers and challenges
  • Vendor landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Key customers
  • Abbott Laboratories - Segment focus
  • ACON Laboratories Inc. - Overview
  • ACON Laboratories Inc. - Product and service
  • ACON Laboratories Inc. - Key offerings
  • ACON Laboratories Inc. - Key customers
  • ACON Laboratories Inc. - Segment focus
  • ARKRAY Inc. - Overview
  • ARKRAY Inc. - Product and service
  • ARKRAY Inc. - Key offerings
  • ARKRAY Inc. - Key customers
  • ARKRAY Inc. - Segment focus
  • Ascensia Diabetes Care Holdings AG - Overview
  • Ascensia Diabetes Care Holdings AG - Product and service
  • Ascensia Diabetes Care Holdings AG - Key offerings
  • Ascensia Diabetes Care Holdings AG - Key customers
  • Ascensia Diabetes Care Holdings AG - Segment focus
  • Becton, Dickinson and Co. - Overview
  • Becton, Dickinson and Co. - Business segments
  • Becton, Dickinson and Co. - Key offerings
  • Becton, Dickinson and Co. - Key customers
  • Becton, Dickinson and Co. - Segment focus
  • B. Braun Melsungen AG - Overview
  • B. Braun Melsungen AG - Business segments
  • B. Braun Melsungen AG - Key offerings
  • B. Braun Melsungen AG - Key customers
  • B. Braun Melsungen AG - Segment focus
  • F. Hoffmann-La Roche Ltd. - Overview
  • F. Hoffmann-La Roche Ltd. - Business segments
  • F. Hoffmann-La Roche Ltd. - Key offerings
  • F. Hoffmann-La Roche Ltd. - Key customers
  • F. Hoffmann-La Roche Ltd. - Segment focus
  • LifeScan IP Holdings LLC - Overview
  • LifeScan IP Holdings LLC - Product and service
  • LifeScan IP Holdings LLC - Key offerings
  • LifeScan IP Holdings LLC - Key customers
  • LifeScan IP Holdings LLC - Segment focus
  • Medtronic Plc - Overview
  • Medtronic Plc - Business segments
  • Medtronic Plc - Key offerings
  • Medtronic Plc - Key customers
  • Medtronic Plc - Segment focus
  • Nipro Corp. - Overview
  • Nipro Corp. - Business segments
  • Nipro Corp. - Key offerings
  • Nipro Corp. - Key customers
  • Nipro Corp. - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global self-monitoring blood glucose strips market: Abbott Laboratories, ACON Laboratories Inc., ARKRAY Inc., Ascensia Diabetes Care Holdings AG, Becton, Dickinson and Co., B. Braun Melsungen AG, F. Hoffmann-La Roche Ltd., LifeScan IP Holdings LLC, Medtronic Plc, and Nipro Corp.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is the availability of test strips made from Indian silk.'

According to the report, one of the major drivers for this market is the increase in the global diabetic population.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • ACONÂ Laboratories Inc.
  • ARKRAY Inc.
  • Ascensia Diabetes Care Holdings AG
  • Becton
  • Dickinson and Co.
  • B. Braun Melsungen AG
  • F. Hoffmann-La Roche Ltd.
  • LifeScan IP Holdings LLC
  • Medtronic Plc
  • Nipro Corp.